These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2545638)

  • 41. [The significance of gold serum level determinations during chrysotherapy in rheumatoid arthritis (author's transl)].
    Bahous I; Müller W; Stojan B
    Med Klin; 1975 Sep; 70(38):1516-21. PubMed ID: 810649
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Methotrexate induced pneumonitis in a young woman with psoriasis and rheumatoid arthritis.
    Schwartz GF; Anderson ST
    J Rheumatol; 1990 Jul; 17(7):980. PubMed ID: 2213769
    [No Abstract]   [Full Text] [Related]  

  • 43. Methotrexate levels, a guide to therapy?
    Edelman J; Russell AS; Biggs DF; Rothwell RS; Coates J
    Clin Exp Rheumatol; 1983; 1(2):153-6. PubMed ID: 6681135
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Pancytopenia during low-dose oral methotrexate therapy of psoriatic arthritis].
    Kohler S; Neumann J; Dürk H; Saal J; Müller GA
    Dtsch Med Wochenschr; 1989 Aug; 114(34):1286-8. PubMed ID: 2766951
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Measurements of red blood cell methotrexate concentrations and lymphocyte subsets during therapy of rheumatoid arthritis.
    Duby S; Karsh J; Prchal JF; Whitehead VM; Osterland CK
    Clin Exp Rheumatol; 1985; 3(1):5-9. PubMed ID: 3978894
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Methotrexate--indications and adverse effects].
    Wolter M
    Hautarzt; 1991 Oct; 42(10):654. PubMed ID: 1757261
    [No Abstract]   [Full Text] [Related]  

  • 47. Methotrexate: its use in the rheumatic diseases.
    Bookbinder SA; Espinoza LR; Fenske NA; Germain BF; Vasey FB
    Clin Exp Rheumatol; 1984; 2(2):185-93. PubMed ID: 6398173
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methotrexate osteopathy in long-term, low-dose methotrexate treatment for psoriasis and rheumatoid arthritis.
    Zonneveld IM; Bakker WK; Dijkstra PF; Bos JD; van Soesbergen RM; Dinant HJ
    Arch Dermatol; 1996 Feb; 132(2):184-7. PubMed ID: 8629827
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Methotrexate use and liver outcomes in psoriasis and rheumatoid arthritis patients: A commentary on "Risk of liver disease in patients with psoriasis, psoriatic arthritis and rheumatoid arthritis receiving methotrexate: A population-based study".
    Gau SY
    J Am Acad Dermatol; 2021 Dec; 85(6):e399-e400. PubMed ID: 34403710
    [No Abstract]   [Full Text] [Related]  

  • 50. Response to: "Methotrexate Use and Liver Outcomes in Psoriasis and Rheumatoid Arthritis Patients: A Commentary on 'Risk of liver disease in patients with psoriasis, psoriatic arthritis and rheumatoid arthritis receiving methotrexate: A population-based study'".
    Gelfand JM; Syed MN
    J Am Acad Dermatol; 2021 Dec; 85(6):e401. PubMed ID: 34403717
    [No Abstract]   [Full Text] [Related]  

  • 51. Effects of a single massive intravenous dose of hydrocortisone in rheumatoid arthritis.
    Haataja M; Kalliomaki JL
    Curr Ther Res Clin Exp; 1975 Jan; 17(1):80-7. PubMed ID: 806432
    [No Abstract]   [Full Text] [Related]  

  • 52. Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis.
    Shergy WJ; Polisson RP; Caldwell DS; Rice JR; Pisetsky DS; Allen NB
    Am J Med; 1988 Dec; 85(6):771-4. PubMed ID: 3195601
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasma reactive nitrogen intermediate levels in patients with clinically active rheumatoid arthritis.
    Wanchu A; Agnihotri N; Deodhar SD; Ganguly NK
    Indian J Med Res; 1996 Oct; 104():263-8. PubMed ID: 8952180
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Delayed methotrexate pneumonitis in rheumatoid arthritis.
    Pourel J; Guillemin F; Fener P; Webanck L; Bene MC; Delorme N
    J Rheumatol; 1991 Feb; 18(2):303-4. PubMed ID: 2023228
    [No Abstract]   [Full Text] [Related]  

  • 55. Cryptococcosis associated with low-dose methotrexate for arthritis.
    Altz-Smith M; Kendall LG; Stamm AM
    Am J Med; 1987 Jul; 83(1):179-81. PubMed ID: 3605168
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neutropenia due to low-dose methotrexate therapy for psoriasis and rheumatoid arthritis may be fatal.
    Mayall B; Poggi G; Parkin JD
    Med J Aust; 1991 Oct; 155(7):480-4. PubMed ID: 1921820
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Repetitive exercise induced ventricular tachycardia in a patient with rheumatoid arthritis taking low dose methotrexate.
    Borek G; Jenzer HR; Frey LD; Locher JT
    J Rheumatol; 1992 Jun; 19(6):1004-5. PubMed ID: 1404112
    [No Abstract]   [Full Text] [Related]  

  • 58. Low-dose methotrexate kinetics in arthritis.
    Edelman J; Biggs DF; Jamali F; Russell AS
    Clin Pharmacol Ther; 1984 Mar; 35(3):382-6. PubMed ID: 6697645
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Effect of Methotrexate on Serum Levels of Trace/Mineral Elements in Patients with Psoriatic Arthritis.
    Gao Y; Li X; Liu T; Liu Z
    Biol Trace Elem Res; 2021 Dec; 199(12):4498-4503. PubMed ID: 33452668
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methotrexate polyglutamate concentrations and association with disease control in rheumatoid arthritis: comment on the article by Stamp et al.
    Dervieux T; Kremer J
    Arthritis Rheum; 2010 Aug; 62(8):2559-60; author reply 2560-1. PubMed ID: 20506252
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.